4204 articles
Distributed in New Zealand by Ophthalmic Instrument Company, the Medmont Meridia Vantage is being positioned as a comprehensive anterior eye imaging platform, with scleral topography its key advance.
Blackfin has unveiled a reimagined version of its classic Pacific line. A study in restraint and purity, this collection is defined by ultra-thin profiles meticulously milled from a solid block of tit
Large analysis of global adverse events reports GLP-1 risks.
On a mission to raise awareness of macular degeneration (MD) and improve eye health for those living in one of New Zealand’s most geographically isolated areas, Macular Degeneration New Zealand (MDNZ)
An ophthalmic spray containing 1% tropicamide and 2.5% phenylephrine has been shown by American researchers to be as effective as traditional eye drops for pupillary dilation in children. Their study,
A University of Auckland study revealed failures in recognising and responding to postoperative deterioration, rather than intraoperative technical errors, underpin most surgical complaints in New Zea
Waikato practice Eye Surgeons has opened the doors to Whanganui’s first private eye clinic. March was a busy month for Eye Surgeons’ founder Dr James McKelvie, associate professor with the University
The World Council of Optometry (WCO) and Alcon have launched a new interactive tool, the Dry Eye Management Map, to support optometrists in navigating dry eye disease (DED) management. Mergi
Researchers found combining optical coherence tomography (OCT) and OCT angiography (OCTA) not only enhances discrimination between people with mild cognitive impairment (MCI), probable Alzheimer’s dis
US researchers have identified an immune cell population that helps maintain normal intraocular pressure (IOP), potentially representing a new glaucoma treatment target. Writing in Immunity, the
UK scientists have discovered that the protein LRG1, found in the bloodstream and tissues, triggers the earliest damage in diabetic retinopathy, paving the way for new treatment pathways. Publ
Strengthening its myopia-management portfolio, CooperVision’s new soft contact lens, MyDay MiSight 1 day, is now available to wearers in New Zealand and Australia. Combining the proven ActivControl Te
